Federal cannabis policy moved deeper into implementation over the past day, with the Drug Enforcement Administration opening specialized registration channels for more medical marijuana businesses while a separate court fight intensified over hemp access through Medicare. In entertainment, Paramount completed its acquisition of Warner Bros. Discovery, shifting one of Hollywood’s largest mergers from planning to integration.
DEA Opens Federal Registration to More Medical Cannabis Businesses
The Drug Enforcement Administration has introduced specialized registration links for state-licensed medical marijuana manufacturers, distributors and analytical laboratories. The new versions of DEA Form 225 expand a federal registration process that initially focused on medical cannabis dispensaries.
Applicants must disclose their state licensing information, identify whether they handle medical or recreational marijuana, specify the cannabis materials involved and answer questions about the criminal or disciplinary histories of the business and key personnel. Reported nonrefundable application fees are $3,699 for manufacturers, $1,850 for distributors and $296 for testing laboratories.
Why It Matters: The forms create a more defined federal entry point for businesses across the medical cannabis supply chain. Analysis: Registration could provide participating operators with greater federal legitimacy, but application costs, inspections, personnel reviews and potentially inconsistent regional enforcement may create substantial compliance burdens.
Source: Marijuana Moment
Opponents Appeal Medicare Hemp Program Ruling
A coalition of marijuana-policy opponents and cannabinoid pharmaceutical interests filed an appellate brief seeking to revive their challenge to a Centers for Medicare & Medicaid Services initiative involving hemp-derived products. A federal district judge dismissed the lawsuit in May after finding that the plaintiffs lacked standing, without deciding the legality of the program itself.
The initiative allows participating providers to furnish eligible hemp products to Medicare beneficiaries, subject to an annual cap of $500 per patient. The providers bear the product costs and may share in resulting healthcare savings with CMS. The appeal argues that the plaintiffs have suffered sufficient competitive, procedural or organizational harm to pursue the case.
Why It Matters: The litigation could influence one of the federal government’s first significant experiments involving beneficiary access to hemp-derived cannabinoid products. Analysis: A successful appeal would not automatically end the initiative, but it could expose the program to a broader judicial review of its authorization, adoption process and potential effects on regulated cannabinoid markets.
Source: Marijuana Moment
Paramount Completes Warner Bros. Discovery Acquisition
Paramount completed its acquisition of Warner Bros. Discovery on October 6, formally creating the combined entertainment company Skydance Corporation. Warner Bros. Discovery became a wholly owned Skydance subsidiary, and its publicly traded shares were converted into cash consideration under the merger agreement.
The company now controls a sweeping collection of film, television, streaming and news assets, including Paramount Pictures, Warner Bros. Pictures, CBS, CNN, Paramount+ and HBO Max. The closing moves management’s focus from regulatory approvals and transaction financing to integration, debt management and operational strategy.
Why It Matters: The completed transaction materially concentrates major Hollywood studios, streaming platforms and news organizations under a single corporate structure. Analysis: Decisions involving jobs, content spending, theatrical distribution, streaming services and debt reduction will now shape competition across the Los Angeles entertainment economy.
Source: Skydance Corporation
What We’re Watching
Over the next 24 to 72 hours, watch for additional DEA guidance on inspections and registration standards, the federal government’s timetable for responding in the Medicare hemp appeal, and early Skydance announcements concerning integration, streaming strategy, staffing and debt reduction.
